Medibio Ltd
ASX:MEB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medibio Ltd
Common Stock
Medibio Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medibio Ltd
ASX:MEB
|
Common Stock
AU$101.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Common Stock
AU$297.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Common Stock
$40m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Common Stock
AU$49.6m
|
CAGR 3-Years
194%
|
CAGR 5-Years
91%
|
CAGR 10-Years
44%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Common Stock
AU$115.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
23%
|
CAGR 10-Years
30%
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Common Stock
AU$75m
|
CAGR 3-Years
10%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
Medibio Ltd
Glance View
Medibio Ltd. engages in the clinical research, product development and early stage commercialization of a mental health technology. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. The firm offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. The company offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.
See Also
What is Medibio Ltd's Common Stock?
Common Stock
101.8m
AUD
Based on the financial report for Jun 30, 2023, Medibio Ltd's Common Stock amounts to 101.8m AUD.
What is Medibio Ltd's Common Stock growth rate?
Common Stock CAGR 5Y
4%
Over the last year, the Common Stock growth was 2%. The average annual Common Stock growth rates for Medibio Ltd have been 4% over the past three years , 4% over the past five years .
